Frolkis AD, Dykeman J, Negrón ME et al. (2013) Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies. Gastroenterology 145(5):996–1006. https://doi.org/10.1053/j.gastro.2013.07.041
Willis MA, Toews I, Soltau SL, Kalff JC, Meerpohl JJ, Vilz TO (2023) Preoperative combined mechanical and oral antibiotic bowel preparation for preventing complications in elective colorectal surgery. Cochrane Colorectal Group, ed. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD014909.pub2
Article PubMed PubMed Central Google Scholar
Dai X, Ge X, Yang J et al. (2017) Increased incidence of prolonged ileus after colectomy for inflammatory bowel diseases under ERAS protocol: a cohort analysis. J Surg Res 212:86–93. https://doi.org/10.1016/j.jss.2016.12.031
Galandiuk S, Kimberling J, Al-Mishlab TG, Stromberg AJ (2005) Perianal Crohn Disease: Predictors of Need for Permanent Diversion. Ann Surg 241(5):796–802. https://doi.org/10.1097/01.sla.0000161030.25860.c1
Article PubMed PubMed Central Google Scholar
Coscia M, Gentilini L, Laureti S et al. (2013) Risk of permanent stoma in extensive Crohn’s colitis: the impact of biological drugs. Colorectal Dis 15(9):1115–1122. https://doi.org/10.1111/codi.12249
Article PubMed CAS Google Scholar
Neary PM, Aiello AC, Stocchi L et al. (2019) High-Risk Ileocolic Anastomoses for Crohn’s Disease: When Is Diversion Indicated? J Crohns Colitis 13(7):856–863. https://doi.org/10.1093/ecco-jcc/jjz004
Cosnes J, Gower-Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140(6):1785-1794.e4. https://doi.org/10.1053/j.gastro.2011.01.055
Muller KR, Prosser R, Bampton P, Mountifield R, Andrews JM (2010) Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease. Inflamm Bowel Dis 16(4):657–663. https://doi.org/10.1002/ibd.21090
Blackwell J, Saxena S, Jayasooriya N et al. (2022) Stoma Formation in Crohn’s disease and the likelihood of antidepressant use: a population-based cohort study. Clin Gastroenterol Hepatol 20(4):e703–e710. https://doi.org/10.1016/j.cgh.2020.12.026
Article PubMed CAS Google Scholar
Kalman TD, Everhov ÅH, Nordenvall C et al. (2020) Decrease in primary but not in secondary abdominal surgery for Crohn’s disease: nationwide cohort study, 1990–2014. Br J Surg 107(11):1529–1538. https://doi.org/10.1002/bjs.11659
Article PubMed CAS Google Scholar
Ma C, Moran GW, Benchimol EI et al. (2017) Surgical rates for Crohn’s disease are decreasing: a population-based time trend analysis and validation study. Am J Gastroenterol 112(12):1840–1848. https://doi.org/10.1038/ajg.2017.394
Article PubMed PubMed Central Google Scholar
Dittrich AE, Sutton RT, Haynes K, Wang H, Fedorak RN, Kroeker KI (2020) Incidence rates for surgery in Crohn’s disease have decreased: a population-based time-trend analysis. Inflamm Bowel Dis 26(12):1909–1916. https://doi.org/10.1093/ibd/izz315
Everhov ÅH, Kalman TD, Söderling J et al. (2022) Probability of stoma in incident patients with Crohn’s Disease in Sweden 2003–2019: a population-based study. Inflamm Bowel Dis 28(8):1160–1168. https://doi.org/10.1093/ibd/izab245
Ma C, Almutairdi A, Tanyingoh D et al. (2019) Reduction in surgical stoma rates in Crohn’s disease: a population-based time trend analysis. Colorectal Dis 21(11):1279–1287. https://doi.org/10.1111/codi.14731
Article PubMed CAS Google Scholar
Geltzeiler CB, Hart KD, Lu KC, Deveney KE, Herzig DO, Tsikitis VL (2015) Trends in the surgical management of Crohn’s disease. J Gastrointest Surg 19(10):1862–1868. https://doi.org/10.1007/s11605-015-2911-3
Xu Y, Yang L, An P, Zhou B, Liu G (2019) Meta-analysis: the influence of preoperative infliximab use on postoperative complications of Crohn’s Disease. Inflamm Bowel Dis 25(2):261–269. https://doi.org/10.1093/ibd/izy246
Kim JY, Zaghiyan K, Lightner A, Fleshner P (2020) Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study. BMC Surg 20(1):46. https://doi.org/10.1186/s12893-020-00698-8
Article PubMed PubMed Central CAS Google Scholar
Lightner AL, McKenna NP, Tse CS et al. (2018) Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn’s Disease. J Crohns Colitis 12(4):402–407. https://doi.org/10.1093/ecco-jcc/jjx163
Kotze PG, Magro DO, Martinez CAR et al. (2018) Adalimumab and postoperative complications of elective intestinal resections in Crohn’s disease: a propensity score case-matched study. Colorectal Dis 20(3):211–218. https://doi.org/10.1111/codi.13929
Iesalnieks I, Kilger A, Gla H, Obermeier F, Agha A, Schlitt HJ (2010) Perforating Crohnʼs ileitis: Delay of surgery is associated with inferior postoperative outcome. Inflamm Bowel Dis 16(12):2125–2130. https://doi.org/10.1002/ibd.21303
Hain E, Maggiori L, Orville M, Tréton X, Bouhnik Y, Panis Y (2019) Diverting Stoma for Refractory Ano-perineal Crohn’s Disease: Is It Really Useful in the Anti-TNF Era? A Multivariate Analysis in 74 Consecutive Patients. J Crohns Colitis 13(5):572–577. https://doi.org/10.1093/ecco-jcc/jjy195
McCurdy JD, Reid J, Yanofsky R et al. (2022) Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study. Inflamm Bowel Dis 28(2):226–233. https://doi.org/10.1093/ibd/izab086
Gomollón F, Dignass A, Annese V et al. (2017) 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis 11(1):3–25. https://doi.org/10.1093/ecco-jcc/jjw168
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L (2017) Crohn’s disease. The Lancet 389(10080):1741–1755. https://doi.org/10.1016/S0140-6736(16)31711-1
Ambe PC, Kurz NR, Nitschke C, Odeh SF, Möslein G, Zirngibl H (2018) Intestinal ostomy: classification, indications, ostomy care and complication management. Dtsch Ärztebl Int 115(11):182
El-Hussuna A, Andersen J, Bisgaard T et al. (2012) Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn’s disease. Scand J Gastroenterol 47(6):662–668. https://doi.org/10.3109/00365521.2012.660540
Article PubMed CAS Google Scholar
Papaconstantinou I, Zeglinas C, Gazouli M et al. (2014) The Impact of Peri-operative Anti-TNF treatment on anastomosis-related complications in Crohn’s Disease Patients. A Critical Review J Gastrointest Surg 18(6):1216–1224. https://doi.org/10.1007/s11605-014-2487-3
Yamamoto T, Spinelli A, Suzuki Y et al. (2016) Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. United Eur Gastroenterol J 4(6):784–793. https://doi.org/10.1177/2050640615600116
Lightner AL, Raffals LE, Mathis KL et al. (2017) Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease. J Crohns Colitis 11(2):185–190. https://doi.org/10.1093/ecco-jcc/jjw147
Rungoe C, Langholz E, Andersson M et al. (2014) Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011. Gut 63(10):1607–1616. https://doi.org/10.1136/gutjnl-2013-305607
Article PubMed CAS Google Scholar
Lakatos PL, Golovics PA, Da
留言 (0)